Evidence map›Paper›PMID 32536024›Full record

ArticleThe oncologist2020

Evolution of Cancer Care in Response to the COVID-19 Pandemic.

Eric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, Waleed Alhazzani, Ahmad Alhuraiji, Roy F Chemaly, Meshari Almuhanna, Robert A Wolff, Nuhad K Ibrahim, Melvin L K Chua and 6 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The oncologist, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Eric A CoomesDivision of Infectious Disease, Department of Medicine, University of Toronto, Toronto, Canada.
Humaid O Al-ShamsiMedical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates; Department of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Emirates Oncology Society, Dubai, United Arab Emirates.ORCID 0000-0003-3819-0500
Brandon M MeyersDepartment of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
Waleed AlhazzaniDepartment of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster University, Hamilton, Canada.
Ahmad AlhuraijiDepartment of Hematology, Kuwait Cancer Control Center, Kuwait City, Kuwait.
Roy F ChemalyDepartment of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Meshari AlmuhannaMin-Sheng General Hospital, Taoyuan District, Taoyuan City, Taiwan.
Robert A WolffDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nuhad K IbrahimDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Melvin L K ChuaDivisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore; Oncology Academic Program, Duke-National University of Singapore Medical School, Singapore; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Sebastien J HotteDepartment of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
Tarek ElfikiWindsor Regional Cancer Center, Windsor, Canada; Department of Oncology, Schulich School of Medicine, University of Western Ontario, London, Canada.
Giuseppe CuriglianoDepartment of Oncology and Hemato-Oncology and Division of Early Drug Development for Innovative Therapy, University of Milan, Milan, Italy; European Institute of Oncology, IRCCS, and University of Milano, Milan, Italy.
Cathy EngVanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
Axel GrotheyWest Cancer Center, University of Tennessee, Memphis, Tennessee, USA.
Conghua XieDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19NeoplasmsHumansPandemicsSARS-CoV-2

Identifiers

PMID32536024
PMCPMC7323244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.